Zobrazeno 1 - 10
of 142
pro vyhledávání: '"David, Good"'
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/d2d2dc22c62a4b30aea94911f2faff61
Publikováno v:
Immunotherapy. 15:323-333
Aplastic anemia is a rare but potentially serious complication of immune checkpoint inhibitor therapy. The authors present a case of pembrolizumab-induced aplastic anemia that was refractory to steroids but had some hematologic response to modified-d
Publikováno v:
Frontiers in Human Neuroscience, Vol 14 (2020)
Chronic stroke survivors with severe contralesional arm paresis face numerous challenges to performing activities of daily living, which largely rely on the use of the less-affected ipsilesional arm. While use of the ipsilesional arm is often encoura
Externí odkaz:
https://doaj.org/article/ac2e220e8cb745dfb1a0912d3d4b98d3
Autor:
Mayowa O. Owolabi, Thomas Platz, David Good, Bruce H. Dobkin, Echezona N. D. Ekechukwu, Leonard Li
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/13f5998d556d4edeb24aac22c8bdbe4c
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0221779 (2020)
BACKGROUNDS:MicroRNAs (miRNA) are a class of non-protein-coding RNAs that have significant biological and pathological functions. The importance of miRNAs as potential cancer diagnostic biomarkers is gaining attention due to their influence in the re
Externí odkaz:
https://doaj.org/article/6f4a5e2205714481a28090b1c2365665
Autor:
Qiang Yi, Stanley Chien, Lingxi Li, Wensen Niu, Yaobin Chen, David Good, Chi-Chih Chen, Rini Sherony
Publikováno v:
Journal of Intelligent and Connected Vehicles, Vol 1, Iss 1, Pp 15-27 (2018)
Purpose - To support the standardized evaluation of bicyclist automatic emergency braking (AEB) systems, test scenarios, test procedures and test system hardware and software tools have been investigated and developed by the Transportation Active Saf
Externí odkaz:
https://doaj.org/article/291b7a62c77a4cf89437685cea543a7a
Autor:
Frank Stephan, Matthias Gross, Anna Grebinyk, Zakaria Aboulbanine, Zohrab Amirkhanyan, Volker Budach, Vincent Henrique Ehrhardt, Angeles Faus-Golfe, Marcus Frohme, Jean-Francois Germond, James David Good, Florian Grüner, David Kaul, Mikhail Krasilnikov, Ron Leavitt, Wim Leemans, Xiangkun Li, Gregor Loisch, Frieder Müller, Georg Müller, Frank Obier, Anne Oppelt, Sebastian Philipp, Houjun Qian, Judith Reindl, Felix Riemer, Martin Sack, Michael Schmitz, Tobias Schnautz, Andreas Schüller, Theresa Staufer, Christian Stegmann, Gohar Tsakanova, Marie-Catherine Vozenin, Hans Weise, Steven Worm, Daniel Zips
Publikováno v:
Physica Medica. 104:174-187
Autor:
Kathrin Tyryshkin, Alison Moore, David Good, Jesse Popov, Susan Crocker, Michael J. Rauh, Tara Baetz, David P. LeBrun
Publikováno v:
Leukemia & Lymphoma. 64:119-129
TCF3 is a lymphopoietic transcription factor that acquires somatic driver mutations in diffuse large B-cell lymphoma (DLBCL). Hypothesizing that expression patterns of TCF3-regulated genes can inform clinical management, we found that unsupervised cl
Autor:
Mark Bosch, Ariz Akhter, Bingshu E. Chen, Adnan Mansoor, David Lebrun, David Good, Michael Crump, Lois Shepherd, David W. Scott, Douglas A. Stewart
Publikováno v:
Haematologica, Vol 103, Iss 2 (2018)
The objective of this study was to create a bioclinical model, based on clinical and molecular predictors of event-free and overall survival for relapsed/refractory diffuse large B-cell lymphoma patients treated on the Canadian Cancer Trials Group (C
Externí odkaz:
https://doaj.org/article/9f5b230250a04487a536cc021860b2e8
Autor:
Harriet Feilotter, David Good, Annette E. Hay, Nancy Carson, Christina K. Ferrone, Brooke Snetsinger, Michael J. Rauh, Guillaume Richard-Carpentier, Susan Crocker, Grace Zhang, Xiao Zhang, Barnaba Werunga, Graeme Quest, Laura Semenuk, Henry K. Wong, Janet Lui
Publikováno v:
The Journal of Molecular Diagnostics. 23:1292-1305
The identification of clinically significant genes recurrently mutated in myeloid malignancies necessitates expanding diagnostic testing with higher throughput, such as targeted next-generation sequencing. We present validation of the Thermo Fisher O